The opening of the center was successfully conducted to participate in a clinical trial of a biological therapy drug for the treatment of patients with moderate to severe chronic plaque psoriasis, sponsored by Binnopharm Group LLC.
The opening of the center was successfully conducted to participate in a clinical trial of a biological therapy drug for the treatment of patients with moderate to severe chronic plaque psoriasis, sponsored by Binnopharm Group LLC.




























